Related Experiment Video
Updated: Jan 9, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Pediatric Cancer Survivorship: A Review
Erika Foerst1, Vincent Cendan1, Bhumika Gandhi1,2
1MedStar Georgetown University Hospital, Washington, DC.
None:
Following cancer treatment, childhood cancer survivors (CCS) are at risk for adverse physical, psychosocial, functional, and behavioral long-term health outcomes, known as "late effects." Risk for late effects is individualized based on the survivor's treatment exposures and can occur years or decades after treatment. Lifelong survivorship care is needed for screening, prevention, and treatment of late effects. Studies have shown that survivor-focused care declines over time; however, survivors remain engaged with regular medical care. It is important for primary care health care professionals to be aware of resources when caring for this unique population. Multiple domestic and international guidelines are available to provide recommended evaluations for cancer survivors based on their treatment exposures. This review highlights important topics relevant for health care professionals caring for CCS, including organ system-specific late effects, psychosocial care, subsequent neoplasms, immunizations, and transition of medical care.
Related Concept Videos
Cancer Survival Analysis
Treatment Resistant Cancers
Pharmacokinetics in Pediatric Patients: Drug Excretion
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

